Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders

Our recent 8-week, randomized, placebo-controlled trial of fluoxetine in adolescents (ages 12–17 years) with comorbid depression and substance use disorder (SUD) did not detect a significant antidepressant treatment effect. The purpose of this secondary analysis was to explore moderators of the effe...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hirschtritt, Matthew E., Pagano, Maria E., Christian, Kelly M., McNamara, Nora K., Stansbrey, Robert J., Lingler, Jacqui, Faber, Jon E., Demeter, Christine A., Bedoya, Denise, Findling, Robert L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3415216/
https://ncbi.nlm.nih.gov/pubmed/22116008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2011.09.010
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky